Related references
Note: Only part of the references are listed.Targeting B Cells in Atherosclerosis Closing the Gap From Bench to Bedside
Dimitrios Tsiantoulas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
The efficacy of novel B cell biologics as the future of SLE treatment: A review
Ameer Kamal et al.
AUTOIMMUNITY REVIEWS (2014)
Disease Control and Safety of Belimumab Plus Standard Therapy Over 7 Years in Patients with Systemic Lupus Erythematosus
Ellen M. Ginzler et al.
JOURNAL OF RHEUMATOLOGY (2014)
A case of progressive multifocal leukoencephalopathy in a lupus patient treated with belimumab
C. A. Fredericks et al.
LUPUS (2014)
The BAFF/APRIL system in SLE pathogenesis
Fabien B. Vincent et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Post-marketing Experiences with Belimumab in the Treatment of SLE Patients
Anca D. Askanase et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2014)
Favorable Response to Belimumab in Childhood-Onset Systemic Lupus Erythematosus
Joyce S. Hui-Yuen et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials
Richard Furie et al.
LUPUS SCIENCE & MEDICINE (2014)
The TACI Receptor Regulates T-Cell-Independent Marginal Zone B Cell Responses through Innate Activation-Induced Cell Death
William A. Figgett et al.
IMMUNITY (2013)
Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus
D. J. Wallace et al.
LUPUS (2013)
Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
M. A. Dooley et al.
LUPUS (2013)
B-cell targeted therapeutics in clinical development
Stephan Blueml et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
Ronald F. van Vollenhoven et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2012)
The pathogenesis of systemic lupus erythematosus-an update
Jinyoung Choi et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort
M. B. Urowitz et al.
ARTHRITIS CARE & RESEARCH (2012)
B lymphocyte stimulator levels in systemic lupus erythematosus: Higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels
Lauren L. Ritterhouse et al.
ARTHRITIS AND RHEUMATISM (2011)
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS AND RHEUMATISM (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
The role of B cells in lupus pathogenesis
Emil Nashi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2008)
Mechanisms of disease: Systemic lupus erythematosus
Anisur Rahman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Systemic lupus erythematosus
David P. D'Cruz et al.
LANCET (2007)
Reproductive and menopausal factors and risk of systemic lupus erythematosus in women
Karen H. Costenbader et al.
ARTHRITIS AND RHEUMATISM (2007)
Mortality in systemic lupus erythematosus
S. Bernatsky et al.
ARTHRITIS AND RHEUMATISM (2006)
Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator
KP Baker et al.
ARTHRITIS AND RHEUMATISM (2003)
Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus
J Zhang et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
